CHPA Statement Regarding FDA Proposed Labeling Changes on Over-the-Counter Analgesics

Washington, D.C. (December 19, 2006)—Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the U.S. Food and Drug Administration’s (FDA’s) proposal on labeling changes for over-the-counter analgesics:

“CHPA member companies take very seriously the safe use of OTC medicines. The Agency’s proposal is based on a review by FDA’s Nonprescription Drugs Advisory Committee meeting in September 2002, after which many of our member companies implemented label improvements. As FDA states in this proposed rule, consumers should remain confident that over-the-counter analgesics continue to be safe and effective.

"Our member companies remain dedicated to helping consumers better understand how to safely take these medicines and to consult their doctor, pharmacist, or other healthcare provider should they have any questions. We welcome changes which can effectively help consumers better understand how to safely take these medicines. The reality is, however, that over-the-counter medicines are real medicines with real risks if misused. We reiterate that it is extremely important that consumers know to read and follow the directions on every over-the counter medicine they are taking.”

Contacts: Elizabeth Assey and Mimi Pappas, 202.429.9260

CHPA is the 125-year-old trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.